Identifying Ontarians with Type 2 Diabetes Mellitus in Administrative Data: A Comparison of Two Case Definitions.
Autor: | Houlden RL; Division of Endocrinology, Queen's University, Kingston, ON, Canada. houldenr@queensu.ca., Thayalan N; Division of Endocrinology, Queen's University, Kingston, ON, Canada., Shi S; IQVIA Solutions Canada Inc, Mississauga, ON, Canada., Kukaswadia A; IQVIA Solutions Canada Inc, Mississauga, ON, Canada., Mau G; Novo Nordisk Canada Inc, Mississauga, ON, Canada., Liu A; Novo Nordisk A/S, Bagsværd, Denmark. |
---|---|
Jazyk: | angličtina |
Zdroj: | Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Mar; Vol. 15 (3), pp. 677-689. Date of Electronic Publication: 2024 Feb 10. |
DOI: | 10.1007/s13300-024-01535-4 |
Abstrakt: | Introduction: This study compared two previously validated sensitive and specific diabetes case definitions to explore the impact of different classification methods in Ontario ICES administrative data. Methods: This study included patients captured by the Ontario Diabetes Database with type 2 diabetes using either the sensitive cohort definition (≥ 2 physician visits for diabetes within 1 year or ≥ 1 drug claim for diabetes or ≥ 1 hospitalization with diabetes), or the specific cohort definition (≥ 3 physician visits for diabetes within 1 year), between October 1, 2013 to September 30, 2015. Each cohort's demographic and clinical features were described using descriptive analysis. Results: Using sensitive and specific definitions, 1,093,812 and 783,228 patients with type 2 diabetes were identified, respectively. Overall, the demographic and clinical characteristics were similar between cohorts. Patients in the sensitive cohort had mean age of 64.1 years and were 52.4% male, compared to 64.8 years and 53.6% male in the specific cohort. In the sensitive and specific cohorts respectively, 64.4% and 55.7% of patients reported one-year mean HbA1c of < 7% (53 mmol/mol) and 25.3% and 31.5% reported levels between 7.0-8.5% (53-69 mmol/mol). Conclusions: Although sample sizes were different between sensitive and specific cohorts, demographic and clinical characteristics were similar. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |